Reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer (opens in a new tab)
Gynecol Oncol
Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsEndometrial Neoplasms
Dr. Juraj Kavecansky, MD
NPI1942592563PAC ID0547401119
- Part D claims, 2024
- 1,062
- Publications
- 10
- Clinical trials
- 1
- Hospital affiliations
- 1
- Industry payments
- $2,115
- Practice address
- 901 Nevin Ave, Richmond, CA 94801
- Practice phone
- Call (510) 307-1555
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Richmond Medical Center
Richmond, California
Find Dr. Kavecansky's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Juraj Kavecansky is a medical oncologist in Richmond, California
Dr. Kavecansky practices at Richmond Medical Center in Richmond, California.
Dr. Kavecansky's NPI, 1942592563, was assigned on May 16, 2011. Dr. Kavecansky graduated from Ohio State College of Medicine in 2011. Dr. Kavecansky holds California license A148318.
NPI and contact details
- NPI
- 1942592563NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0547401119
- NPI enumeration date
- May 16, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (510) 307-1555
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Juraj Kavecansky practices at Richmond Medical Center in Richmond, California
Dr. Kavecansky's primary practice is Richmond Medical Center, at 901 Nevin Ave, Richmond, CA 94801 in Contra Costa County. The practice phone is (510) 307-1555.
- Richmond Medical Center901 Nevin Ave, Richmond, CA 94801 · Contra Costa CountyPhone(510) 307-1555
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Juraj Kavecansky is affiliated with 2 sites of care and 2 medical groups
Dr. Kavecansky's primary practice is Richmond Medical Center in Richmond, California. Dr. Kavecansky is also affiliated with Walnut Creek Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Kavecansky to 1 more medical group, named with a free account.
Richmond Medical CenterPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Juraj Kavecansky's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kavecansky practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Richmond Medical Center | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kavecansky practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Juraj Kavecansky is one of 415 medical oncologists in California
Medical oncology is Dr. Kavecansky's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kavecansky is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kavecansky's licenses on file in 4 states: California, Georgia, New York and Ohio.
Specialties and state licenses
- Medical oncology, CaliforniaPrimary
- Georgia license
- New York license
- Ohio license
Medical oncologists near Dr. Kavecansky
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Juraj Kavecansky's patients have a median age of 65
Across all payers, Dmand AI patient panel data puts Dr. Kavecansky's median patient age at 65, with 73% women.
Dr. Kavecansky's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 65
Patient panel by sex, all payers
- Women73%
- Men26%
Source: Dmand AI Patient Panel Data
Dr. Juraj Kavecansky wrote 1,062 Medicare Part D claims in 2024
In 2024, Dr. Kavecansky wrote 1,062 Medicare Part D claims for 197 patients. 81% of them were for generic drugs. CMS names the drug for 735 of them, across 27 drugs with 11 or more claims each, at $2,761,227 in total drug cost. In 2023, CMS named 677 claims across 28 drugs.
Part D claims, 20241,062
Drugs named by CMS27
Total drug cost$2.8M
Part D patients197
Dr. Kavecansky's Part D claims by kind of drug, 2024
- Generic855 claims81%
- Brand-name and other207 claims19%
Dr. Kavecansky's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kavecansky's Part D claims, 2024
- Opioids12%124 of 1,062 claims
- Antibiotics2%22 of 1,062 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6772024: 7359%
Drugs named by CMS: 27 in 2024, 28 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Juraj Kavecansky offers telehealth to Medicare patients
Dr. Kavecansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kavecansky as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find medical oncologists like Dr. Kavecansky by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Juraj Kavecansky has 10 publications on record
Dmand AI links 10 papers to Dr. Kavecansky, published from 2011 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols and Endometrial Neoplasms. Dr. Kavecansky's most frequent co-authors are Gwendolyn Hanh Ho, MD, Ashok P. Pai, MD and Jahan Tavakoli, MD.
Papers10
Years published2011 to 2025
Dr. Kavecansky's papers by year, 2011 to 2025
Topics Dr. Kavecansky writes about most
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols
- Endometrial Neoplasms
- Anticoagulants
- Carboplatin
- COVID-19
- Paclitaxel
Dr. Kavecansky's most frequent co-authors
- Gwendolyn Hanh Ho, MD3 shared papers
- Ashok P. Pai, MD3 shared papers
- Jahan Tavakoli, MD3 shared papers
Recent publications by Dr. Kavecansky
Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsCarboplatin
Am J Obstet Gynecol
EthnicityHealthcare DisparitiesOvarian Neoplasms
Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsCarboplatin
See who Dr. Kavecansky researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kavecansky works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Juraj Kavecansky has worked on 1 clinical trial
Dmand AI links Dr. Kavecansky to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinosarcoma and Neoplasms, Complex and Mixed.
Conditions in Dr. Kavecansky's trials
- Carcinosarcoma
- Neoplasms, Complex and Mixed
Investigators on the most trials with Dr. Kavecansky
- Ivy Elizabeth Abraham1 shared trial
- Carol Aghajanian, MD1 shared trial
- Krishna C. Alluri, MD1 shared trial
Recent clinical trials with Dr. Kavecansky
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (opens in a new tab)
Active, not recruitingPhase 3
CarcinosarcomaNeoplasms, Complex and MixedCarboplatinPaclitaxelPembrolizumab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Juraj Kavecansky received $2,115 in industry payments from 2016 to 2024
CMS Open Payments shows 19 general payments to Dr. Kavecansky from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 90% of the total. Millennium Pharmaceuticals, Inc. paid the most, $606.
General payments to Dr. Kavecansky by program year, 2016 to 2024
General payments to Dr. Kavecansky by kind, 2016 to 2024
$2.1Kin total
- Food and beverage$1,91090%
- Education$20510%
Companies that paid Dr. Kavecansky the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Juraj Kavecansky graduated from Ohio State College of Medicine
Dr. Kavecansky graduated from Ohio State College of Medicine in 2011.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Juraj Kavecansky accepts plans from 2 insurance carriers
Dr. Kavecansky is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Kaiser Permanente
- CMS Medicare
Plan types Dr. Kavecansky accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Juraj Kavecansky's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Juraj Kavecansky
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Juraj Kavecansky's NPI number?
Dr. Juraj Kavecansky's NPI number is 1942592563. It was assigned on May 16, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Juraj Kavecansky?
Dr. Juraj Kavecansky is a medical oncologist in Richmond, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Juraj Kavecansky practice?
Dr. Kavecansky practices at 901 Nevin Ave, Richmond, CA 94801. Dr. Kavecansky's primary practice is Richmond Medical Center in Richmond, California. Dmand AI also links Dr. Kavecansky to 1 medical group.
What is Dr. Juraj Kavecansky's office phone number?
The practice phone on file for Dr. Kavecansky is (510) 307-1555.
What is Dr. Juraj Kavecansky's medical license number?
Dr. Kavecansky holds California license A148318, one of the licenses on file in 4 states.
Which states has Dr. Juraj Kavecansky been licensed in?
Dmand AI has state licenses on file for Dr. Kavecansky in California (2017 to 2027), Georgia (2025 to 2027), New York (2014 to 2018) and Ohio (2011 to 2015).
Which hospitals is Dr. Juraj Kavecansky affiliated with?
Dr. Kavecansky is affiliated with Walnut Creek Medical Center.
What medical group is Dr. Juraj Kavecansky part of?
Dr. Kavecansky is linked to The Permanente Medical Group, Inc. Dmand AI links Dr. Kavecansky to 1 more medical group.
Does Dr. Juraj Kavecansky accept Medicare?
Yes. CMS lists Dr. Kavecansky as accepting Medicare assignment.
Does Dr. Juraj Kavecansky offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kavecansky as offering telehealth services.
Show 8 more questionsShow fewer questions
Is Dr. Juraj Kavecansky board certified?
Yes. Dr. Kavecansky is board certified in hematology by the American Board of Internal Medicine.
Where did Dr. Juraj Kavecansky go to medical school?
Dr. Kavecansky graduated from Ohio State College of Medicine in 2011.
What drugs does Dr. Juraj Kavecansky prescribe most?
In 2024 Medicare Part D data, Dr. Kavecansky's most prescribed drugs by claims were Hydroxyurea, Lenalidomide and Hydrocodone-Acetaminophen.
Has Dr. Juraj Kavecansky received payments from drug or device companies?
CMS Open Payments shows $2,115 in general payments to Dr. Kavecansky from 8 companies from 2016 to 2024. The largest total came from Millennium Pharmaceuticals, Inc.
How long has Dr. Juraj Kavecansky been practicing?
Dr. Kavecansky graduated from medical school in 2011, 15 years ago.
Does Dr. Juraj Kavecansky do research?
Dmand AI links 10 publications to Dr. Kavecansky, published from 2011 to 2025. Dr. Kavecansky has worked on 1 clinical trial.
Who does Dr. Juraj Kavecansky publish with?
Dr. Kavecansky's most frequent co-authors are Gwendolyn Hanh Ho, MD (3 shared papers), Ashok P. Pai, MD (3 shared papers) and Jahan Tavakoli, MD (3 shared papers).
What insurance does Dr. Juraj Kavecansky accept?
Dr. Kavecansky is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card